Quetiapine Tablet, Extended Release
Product Images NDC 29300-308

10 FDA label images from Unichem Pharmaceuticals (usa), Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 29300-308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 01)

Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 01)
Chemical structure diagram of quetiapine and an accompanying compound, likely depicting the molecular structure of quetiapine and a related acid component. The image shows the arrangement of rings, nitrogen, sulfur, oxygen, and carbon atoms as part of the molecular formula.*
FDA Label Image

Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 02)

Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 02)
A line graph showing the proportion of patients with relapse (%) over time (months) comparing PLA (placebo) and QTP XR (quetiapine extended-release). The PLA group shows a steadily increasing relapse proportion, while the QTP XR group remains lower throughout the observation period up to 7 months.*
FDA Label Image

Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 03)

Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 03)
A line graph depicting the proportion of patients with relapse (%) over time (weeks). Two treatment groups are shown: one labeled QTP + LIVAL and the other PLA + LIVAL. The graph illustrates the relapse rates for each group across a 100-week period, with relapse proportion on the y-axis and time on the x-axis.*
FDA Label Image

Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 04)

Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 04)
A line graph showing the proportion of patients with relapse (%) over time in weeks for two groups labeled as QTP+LIVAL and PLA+LIVAL. The QTP+LIVAL group has a lower relapse proportion that increases gradually, while the PLA+LIVAL group shows a higher and faster increase in relapse proportion over the 100-week period.*
FDA Label Image

Image (C5ece454 9c87 42df A9f9 Fc9806d7c312 05)

FDA Label Image

Quetiapine Exended-release Tablets Usp, 50 mg (C5ece454 9c87 42df A9f9 Fc9806d7c312 06)

Quetiapine Exended-release Tablets Usp, 50 mg (C5ece454 9c87 42df A9f9 Fc9806d7c312 06)
Label for Quetiapine Extended-Release Tablets, USP 50 mg oral tablet, manufactured by Unichem Laboratories Ltd. for Unichem Pharmaceuticals (USA), Inc. The label includes dosage instructions indicating once daily use, container and storage information, and a barcode. The package contains 60 tablets. The label emphasizes dispensing the accompanying Medication Guide to each patient.*
FDA Label Image

Quetiapine Extended-release Tablets Usp, 150 mg (C5ece454 9c87 42df A9f9 Fc9806d7c312 07)

Quetiapine Extended-release Tablets Usp, 150 mg (C5ece454 9c87 42df A9f9 Fc9806d7c312 07)
Label for Quetiapine Extended-Release Tablets, USP, 150 mg strength. The label indicates the product is prescribed once daily and is packaged as 60 tablets. It includes storage instructions to keep between 20°C to 25°C, a warning to keep out of reach of children, and dispensing guidance for pharmacists. Manufactured by Unichem Laboratories Ltd., India, and marketed by Unichem Pharmaceuticals (USA), Inc.*
FDA Label Image

Quetiapine Extended-release Tablets Usp, 200 mg (C5ece454 9c87 42df A9f9 Fc9806d7c312 08)

Quetiapine Extended-release Tablets Usp, 200 mg (C5ece454 9c87 42df A9f9 Fc9806d7c312 08)
Label for Quetiapine Extended-Release Tablets, USP 200 mg, oral tablet form with 60 tablets per container. Manufactured by Unichem Laboratories Ltd and labeled by Unichem Pharmaceuticals (USA), Inc. The label includes directions for use, storage instructions, and a warning to keep out of reach of children. The National Drug Code (NDC) is 29300-310-16.*
FDA Label Image

Quetiapine Extended-release Tablets, Usp, 300 mg (C5ece454 9c87 42df A9f9 Fc9806d7c312 09)

Quetiapine Extended-release Tablets, Usp, 300 mg (C5ece454 9c87 42df A9f9 Fc9806d7c312 09)
Label for Quetiapine Extended-Release Tablets, USP 300 mg, 60 count bottle. The label includes dosing instructions to take once daily and storage conditions. Manufactured by Unichem Laboratories Ltd and marketed by Unichem Pharmaceuticals (USA), Inc. The label displays the NDC number 29300-311-16 and a barcode.*
FDA Label Image

Quetiapine Extended-release Tablets Usp, 400 mg (C5ece454 9c87 42df A9f9 Fc9806d7c312 10)

Quetiapine Extended-release Tablets Usp, 400 mg (C5ece454 9c87 42df A9f9 Fc9806d7c312 10)
Label for Quetiapine Extended-Release Tablets, USP, 400 mg strength, manufactured by Unichem Laboratories Ltd. and labeled by Unichem Pharmaceuticals (USA), Inc. The label indicates a 60-tablet count, oral route, with instructions to swallow whole and dispense once daily. Storage and handling warnings, dosage details, and an NDC number 29300-312-16 are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.